Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 8.43% institutional investors, 1.41% insiders, and 90.17% retail investors. Bvf inc/il is the largest institutional shareholder, holding 12.12% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	8.43%	1.41%	90.17%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	12.12%	$25.93M
Ra capital management	3.57M	6.87%	$14.69M
Vanguard group	2.89M	5.57%	$11.93M
Sphera funds management	2.55M	4.91%	$10.51M
First light asset management	2.33M	4.48%	$9.59M
Blue owl capital lp	1.96M	3.77%	$8.07M
Woodline partners lp	1.67M	3.22%	$6.89M
Schonfeld strategic advisors	1.52M	2.92%	$6.24M
Ensign peak advisors	1.26M	2.44%	$5.21M
Nantahala capital management	1.15M	2.21%	$4.73M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sanofi	814.98K	1.93%	$3.36M
Sphera funds management	2.55M	1.90%	$10.51M
Blue owl capital lp	1.96M	1.86%	$8.07M
Velan capital investment management lp	323.97K	1.15%	$1.33M
Cm management	275.00K	1.01%	$1.13M
Acuta capital partners	235.75K	0.98%	$971.29K
First light asset management	2.33M	0.92%	$9.59M
Bvf inc/il	6.29M	0.88%	$25.93M
Exome asset management	256.37K	0.79%	$1.06M
Ikarian capital	1.13M	0.63%	$4.64M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	3.57M	0.20%	3.57M
First light asset management	2.33M	0.92%	2.33M
Blue owl capital lp	1.96M	1.86%	1.96M
Vanguard group	2.89M	0.00%	1.33M
Sphera funds management	2.55M	1.90%	1.25M

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-2.36M
Zimmer partners, lp	750.00K	0.05%	-684.73K
Dimensional fund advisors lp	23.03K	-	-11.19K
Two sigma securities	-	-	-11.03K
Citadel advisors	-	-	-1.40K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	3.57M	0.20%	3.57M	$14.69M
First light asset management	2.33M	0.92%	2.33M	$9.59M
Blue owl capital lp	1.96M	1.86%	1.96M	$8.07M
Ikarian capital	1.13M	0.63%	1.13M	$4.64M
Point72 asset management	1.09M	0.01%	1.09M	$4.51M

Sold Out

Holder	Change
Jpmorgan chase	-97.00
Wells fargo & company/mn	-189.00
Citadel advisors	-1.40K
Two sigma securities	-11.03K
Armistice capital	-2.36M

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	17	-48.48%	4,377,486	-76.32%	8	0.67%	12	-	-	-100.00%
Sep 30, 2024	33	6.45%	18,485,827	1.24%	35	0.96%	12	-42.86%	6	500.00%
Jun 30, 2024	31	3.33%	18,259,810	90.30%	60	3.88%	21	90.91%	1	-85.71%
Mar 31, 2024	30	3.45%	9,595,061	4.83%	39	4.25%	11	-8.33%	7	16.67%
Dec 31, 2023	29	3.57%	9,153,168	2.64%	30	2.21%	12	9.09%	6	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.88M	3.15%	50.95K
Vanguard US Total Market Shares ETF	1.15M	1.92%	-
Vanguard Institutional Extnd Mkt Idx Tr	974.99K	1.63%	-
Fidelity Extended Market Index	325.64K	0.54%	-2.07K
Inspire Fidelis Multi Factor ETF	187.76K	0.31%	-
iShares Micro-Cap ETF	127.99K	0.21%	-
Fidelity Total Market Index	124.19K	0.21%	-99.00
Extended Equity Market Fund K	121.50K	0.20%	372.00
BlackRock Extended Equity Market K	79.41K	0.20%	-34.00
EAM Ultra Micro Cap	109.56K	0.18%	-5.91K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2035 Q1	-	-
2025 Q1	-	-
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 8.43%, followed by 1.41% insiders and 90.16% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 12.12%), Ra capital management (3.57M shares, 6.87%), and Vanguard group (2.89M shares, 5.57%). Together, they hold 24.55% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sanofi is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.93% of its assets in 814.98K Eledon Pharmaceuticals shares, valued at 3.36M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.15% of its total shares outstanding invested in 1.88M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools